Physician
Valley Pathology Medical Associates INC
Valley Pathology Medical Associates INC was paid $3.19M by Medicaid between Jan 2018 and Dec 2024, across 149 billing codes. Its largest line is 88307, — 12% of everything it billed.
33Billing provider infoVALLEY PATHOLOGY MEDICAL ASSOCIATES INC
ESCONDIDO, CA 92029
ESCONDIDO, CA 92029
33aNPI1811081797assigned 10/03/2006
33bProvider typeBlood Banking & Transfusion Medicine Physician
28Total paid$3.19M
24GClaims1,396,037
24DCodes billed149
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Blood Banking & Transfusion Medicine Physician providers in California
Rank by total paid#2 of 8
Median peer was paid$236K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 181,413 | $353K | |
| 2019 | 187,765 | $418K | |
| 2020 | 183,568 | $390K | |
| 2021 | 202,836 | $484K | |
| 2022 | 214,542 | $554K | |
| 2023 | 232,645 | $536K | |
| 2024incomplete | 193,268 | $454K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88307 | 12% | 5,500 | 5,454 | $373K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 8.8% | 7,073 | 6,496 | $281K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8.7% | 8,589 | 7,659 | $279K |
| 80048 | Basic metabolic panel (calcium, ionized) | 6.7% | 156,695 | 96,811 | $214K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.0% | 7,634 | 7,124 | $191K |
| 82962 | 5.9% | 35,030 | 11,504 | $188K | |
| 80053 | Comprehensive metabolic panel | 3.9% | 72,282 | 49,035 | $123K |
| 85027 | 3.7% | 100,822 | 60,551 | $118K | |
| 84315 | 2.2% | 119,676 | 82,289 | $70K | |
| 80076 | 2.1% | 59,173 | 48,100 | $66K | |
| 83690 | 2.0% | 57,297 | 49,658 | $63K | |
| 83735 | 2.0% | 51,136 | 26,360 | $63K |
137 more codes
| 83880 | 1.7% | 9,456 | $54K | |
| 82805 | 1.7% | 9,266 | $54K | |
| 87040 | 1.5% | 15,880 | $48K | |
| 81001 | 1.5% | 65,611 | $47K | |
| 88300 | 1.4% | 7,312 | $46K | |
| 83605 | 1.4% | 22,286 | $43K | |
| 84484 | 1.3% | 22,050 | $42K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 15,564 | $42K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 29,750 | $42K |
| 88342 | 1.1% | 967 | $36K | |
| 84145 | <1% | 7,074 | $29K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 23,084 | $28K |
| 87077 | <1% | 15,293 | $26K | |
| 85730 | <1% | 20,743 | $26K | |
| 85060 | <1% | 2,326 | $24K | |
| 85610 | <1% | 34,568 | $24K | |
| 83020 | <1% | 12,021 | $24K | |
| 88304 | <1% | 1,035 | $24K | |
| 84100 | <1% | 26,074 | $21K | |
| 85379 | <1% | 10,097 | $21K | |
| 84703 | <1% | 17,943 | $20K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12,239 | $20K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,084 | $20K |
| 82550 | <1% | 14,084 | $17K | |
| 86885 | <1% | 17,250 | $17K | |
| 86901 | <1% | 33,153 | $16K | |
| 80202 | <1% | 6,319 | $15K | |
| 80061 | Lipid panel | <1% | 6,357 | $14K |
| 84702 | <1% | 5,593 | $13K | |
| 87070 | <1% | 7,866 | $12K | |
| 86900 | <1% | 26,010 | $12K | |
| 82140 | <1% | 4,634 | $11K | |
| 87186 | <1% | 6,446 | $11K | |
| 87149 | <1% | 687 | $11K | |
| 87081 | <1% | 9,589 | $10K | |
| 80074 | <1% | 1,256 | $9K | |
| 81003 | <1% | 25,590 | $9K | |
| 86140 | <1% | 11,547 | $9K | |
| 87075 | <1% | 4,579 | $8K | |
| 86922 | <1% | 2,575 | $8K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,458 | $8K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,451 | $8K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,026 | $7K |
| 84132 | <1% | 9,238 | $7K | |
| 89051 | <1% | 1,856 | $7K | |
| 87503 | <1% | 2,076 | $6K | |
| 82728 | <1% | 2,607 | $6K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 249 | $6K |
| 85576 | <1% | 2,173 | $5K | |
| 82247 | <1% | 6,047 | $5K | |
| 85007 | <1% | 10,209 | $5K | |
| 84466 | <1% | 2,494 | $5K | |
| 87205 | <1% | 6,599 | $5K | |
| 82248 | <1% | 6,974 | $5K | |
| 85384 | <1% | 3,058 | $5K | |
| 86077 | <1% | 162 | $5K | |
| 86880 | <1% | 4,804 | $5K | |
| 87400 | <1% | 4,151 | $4K | |
| 82010 | <1% | 2,831 | $4K | |
| 85652 | <1% | 7,359 | $4K | |
| 82570 | <1% | 3,852 | $3K | |
| 83615 | <1% | 3,473 | $3K | |
| 82746 | <1% | 1,334 | $3K | |
| 82565 | <1% | 4,203 | $3K | |
| 84439 | <1% | 2,090 | $3K | |
| 82607 | <1% | 1,193 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 706 | $3K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 477 | $3K |
| 80164 | <1% | 1,164 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 913 | $3K |
| 86780 | <1% | 1,171 | $2K | |
| 87324 | <1% | 1,432 | $2K | |
| 80069 | <1% | 1,665 | $2K | |
| 87147 | <1% | 2,749 | $2K | |
| 84450 | <1% | 3,218 | $2K | |
| 87340 | <1% | 1,326 | $2K | |
| 83930 | <1% | 1,850 | $2K | |
| 82553 | <1% | 1,004 | $2K | |
| 84550 | <1% | 3,184 | $2K | |
| 87449 | <1% | 1,297 | $2K | |
| 87106 | <1% | 1,191 | $2K | |
| 84460 | <1% | 2,713 | $2K | |
| 87641 | <1% | 330 | $2K | |
| 84156 | <1% | 3,053 | $2K | |
| 82330 | <1% | 875 | $2K | |
| 87427 | <1% | 551 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 65 | $2K |
| 84520 | <1% | 2,831 | $2K | |
| 82947 | <1% | 2,046 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,300 | $1K |
| 87045 | <1% | 832 | $1K | |
| 89230 | <1% | 2,732 | $1K | |
| 87076 | <1% | 550 | $1K | |
| 87210 | <1% | 1,624 | $1K | |
| 86141 | <1% | 482 | $884.15 | |
| 87046 | <1% | 865 | $822.11 | |
| 80047 | <1% | 457 | $740.02 | |
| 86308 | <1% | 773 | $546.38 | |
| 80178 | <1% | 475 | $519.46 | |
| 84300 | <1% | 622 | $501.09 | |
| 80320 | <1% | 1,396 | $430.75 | |
| 84155 | <1% | 846 | $424.65 | |
| 87185 | <1% | 1,049 | $416.08 | |
| 85045 | <1% | 592 | $403.26 | |
| 82150 | <1% | 186 | $386.35 | |
| 87177 | <1% | 241 | $371.47 | |
| 87088 | <1% | 333 | $363.24 | |
| 82945 | <1% | 579 | $346.68 | |
| 87116 | <1% | 166 | $339.64 | |
| 87481 | <1% | 21 | $339.35 | |
| 87102 | <1% | 174 | $313.23 | |
| 82731 | <1% | 27 | $276.87 | |
| 87799 | <1% | 13 | $262.36 | |
| 80329 | <1% | 1,418 | $256.12 | |
| 82533 | <1% | 71 | $215.87 | |
| 83935 | <1% | 175 | $197.05 | |
| 87420 | <1% | 362 | $170.55 | |
| 86762 | <1% | 56 | $132.40 | |
| 86480 | <1% | 12 | $117.59 | |
| 84295 | <1% | 69 | $116.60 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 25 | $99.00 |
| 87176 | <1% | 71 | $94.99 | |
| 83970 | <1% | 13 | $88.65 | |
| 86063 | <1% | 82 | $81.85 | |
| 87511 | <1% | 13 | $71.66 | |
| 87206 | <1% | 33 | $43.53 | |
| 87184 | <1% | 46 | $39.06 | |
| 84478 | <1% | 57 | $35.75 | |
| 86803 | <1% | 12 | $29.19 | |
| 82274 | <1% | 12 | $26.93 | |
| 87015 | <1% | 14 | $22.43 | |
| 83986 | <1% | 26 | $16.40 | |
| 81050 | <1% | 13 | $16.35 | |
| 82042 | <1% | 29 | $16.27 | |
| 87181 | <1% | 18 | $3.92 | |
| 87506 | 0% | 119 | $0.00 | |
| 87505 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKOLINS, JERRY (PRESIDENT)